GlassScriptPhysician profile
Walter L Few
NPI 1699749010
$19,380.40
in general payments reported to CMS, 2019-2025
49 companies · $1,451 in 2025
The $1,451 reported for 2025 was more than what a typical Interventional Cardiology provider received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $3,475 · 2020: $2,497 · 2021: $2,085 · 2022: $3,034 · 2023: $4,124 · 2024: $2,714 · 2025: $1,451.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $8,290.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $8,289.87 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic Vascular, INC. | $2,373.88 | 2019-2020 | |
| Medtronic, INC. | $2,125.97 | 2020-2025 | Aurora Ev-Icd Mri Surescan, Ffrangio, Symplicity G3 |
| Abbott Laboratories | $1,711.84 | 2019-2025 | Aveir, Jot Dx, Assurity |
| Boston Scientific Corporation | $1,052.46 | 2019-2025 | Watchman Access System, Bodyguardian, Watchman Flx |
| Abiomed | $1,016.59 | 2019-2025 | Impella |
| Janssen Pharmaceuticals, INC | $1,013.83 | 2019-2023 | Xarelto |
| Inari Medical, INC. | $953.92 | 2022-2024 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $942.89 | 2019-2025 | Lifevest |
| Novartis Pharmaceuticals Corporation | $934.42 | 2019-2025 | |
| Shockwave Medical, INC | $904.62 | 2021-2024 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter, Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Amgen INC. | $865.83 | 2019-2024 | Repatha |
| Astrazeneca Pharmaceuticals LP | $676.10 | 2019-2025 | Farxiga |
| Pfizer INC. | $595.58 | 2019-2025 | |
| E.R. Squibb & Sons, L.L.C. | $581.11 | 2019-2025 | Camzyos, Eliquis |
| Edwards Lifesciences Corporation | $447.98 | 2019-2025 | Edwards Sapien 3 Transcatheter Heart Valve (Thv), Edwards Sapien 3 Ultra Transcatheter Heart Valve |
Show all 49 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Actelion Pharmaceuticals US, INC. | $301.91 | 2022-2024 | Opsumit, Uptravi |
| Philips North America LLC | $271.58 | 2022-2025 | (Ck4) Mcot, Ecc Solutions |
| Sanofi-Aventis U.S. LLC | $270.25 | 2019-2024 | |
| Novo Nordisk INC | $253.70 | 2023-2025 | Wegovy, Ozempic |
| Boehringer Ingelheim Pharmaceuticals, INC. | $239.35 | 2019-2025 | Jardiance |
| Atricure, INC. | $234.83 | 2022-2023 | |
| Cvrx, INC. | $220.89 | 2024-2025 | Barostim Neo System |
| Chiesi USA, INC. | $204.76 | 2019-2025 | Juxtapid |
| Kestra Medical Technology Services, INC. | $149.27 | 2025 | Assure Wcd |
| Alnylam Pharmaceuticals INC. | $146.04 | 2019-2025 | Amvuttra |
| Teleflex LLC | $74.21 | 2022-2024 | Guideliner |
| Arbor Pharmaceuticals, INC. | $71.48 | 2019-2021 | |
| Terumo Medical Corporation | $71.06 | 2022-2023 | Glidewire, Azur Cx Detachable, Angio-Seal |
| Kowa Pharmaceuticals America, INC. | $62.35 | 2019-2021 | |
| Merck Sharp & Dohme LLC | $59.52 | 2021-2024 | Verquvo |
| Lundbeck LLC | $54.11 | 2019-2020 | |
| Daiichi Sankyo INC. | $51.71 | 2021-2024 | Injectafer |
| Biotronik INC. | $46.29 | 2019 | |
| Cardiva Medical, INC. | $45.87 | 2023-2025 | Cardiva Vascade Mvp Vvcs 6-12f, Optowire |
| Esperion Therapeutics, INC. | $45.28 | 2021 | |
| Astellas Pharma US INC | $38.76 | 2019-2020 | |
| Cordis US Corp. | $35.74 | 2021-2023 | Mynxgrip |
| Regeneron Healthcare Solutions, INC. | $33.78 | 2019-2023 | Evkeeza |
| Bayer Healthcare Pharmaceuticals INC. | $29.13 | 2023-2025 | |
| Kiniksa Pharmaceuticals International, Plc | $28.84 | 2024 | Arcalyst |
| Akcea Therapeutics, INC. | $20.45 | 2019 | |
| Lexicon Pharmaceuticals, INC. | $20.01 | 2024 | |
| Amarin Pharma, INC. | $20.00 | 2020 | |
| Osprey Medical INC | $19.20 | 2020 | |
| Azurity Pharmaceuticals, INC. | $18.81 | 2023 | Edarbyclor |
| Getinge USA Sales, LLC | $15.65 | 2019 | |
| Alexion Pharmaceuticals, INC. | $13.93 | 2022 | |
| Portola Pharmaceuticals, LLC | $13.11 | 2019 | |
| Cardiovascular Systems INC. | $1.51 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Walter Few listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.